Effect of Treatment of Hepatitis C by Directly Acting Antivirals (DAA) on Chronic Hepatitis C, B Coinfected Patients

Impact of Sustained Virological Response on ‎Metabolic Changes and Vitamin-D Status in ‎Patients with Hepatitis C Viral Infection Treated by ‎Direct Acting Antiviral drugs

Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure

Impact of Direct Acting Antiviral Drugs (DAADs) on Cognitive function among Hepatitis C Virus Infected Patients

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients

Effect of Treatment of Chronic Hepatitis C Patients by new Antiviral Drugs

Impact of COVID-19 Infection on Patients with Chronic Liver Disease

Frequency of Hepatocellular Carcinoma in Cirrhotic Patients after Chronic Hepatitis C Infection Treatment with Direct-Acting ‎Antivirals

Impact of Hepatitis C Viral Load in Chronic Kidney Disease Patients‎